Flecainide toxicity late after liver transplantation. Issue 3 (4th May 2021)

• Record Type: Journal Article
• Authors: Elsaid, Ossama; Tecson, Kristen M.; Khan, Hafiza; Assar, Manish D.
• Is Part Of: Proceedings. Volume 34:Issue 3(2021)
• Page Start: 378
• Page End: 379
• Publication Date: 2021-05-04
• Subjects: Antiarrhythmic -- flecainide -- supraventricular tachycardia; Medicine -- Periodicals; Medicine; Medicine -- Periodicals; Periodicals; Electronic journals; 616.005
• DOI: 10.1080/08998280.2020.1871266
• Languages: English
• ISSNs: 0899-8280

Abstract

Abstract: Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide toxicity is a rare condition in which patients may present with bradycardia, widening of QRS, PR prolongation, ventricular tachycardia, syncope, malaise, dizziness, visual disturbance, nausea, vomiting, and/or lethargy. It carries an associated mortality rate of approximately 10%. Herein, we describe the course of a patient who experienced flecainide toxicity in the setting of renal and liver failure.